Double your impact Match My Donation
Working with the natural strength of the body's immune system, immunotherapy has the potential to change the way ALL cancers are treated & cured.
Provide guidance and encouragement to others going through their journey with cancer immunotherapy treatment.
Share Your Story
Create a profile and fill out a questionnaire to identify immunotherapy clinical trials for which you may be eligible.
CALLING HOURS | M-F 8:30 a.m. to 6 p.m. ET
Se habla espanol
Request a call from a Clinical Trial Navigator
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1 immunotherapy for treatment.
Sixteen Team CRI runners ran the 26.2 mile 2018 TCS New York City Marathon and raised an impressive total of $110,000.